Luis Jódar

机构：Pfizer (United States), Global Vaccines (United States) · ORCID：0000-0003-1246-530X

发表论文 221 篇 · 总被引 9554 次 · h-index 44

代表论文

• Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case–control study (2025 · The Lancet Infectious Diseases · 被引 94)
• Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Lower Respiratory Tract Disease (2024 · JAMA Network Open · 被引 46)
• Early effectiveness of the BNT162b2 KP.2 vaccine against COVID-19 in the US Veterans Affairs Healthcare System (2025 · Nature Communications · 被引 33)
• Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System (2024 · Nature Communications · 被引 32)
• Burden of Respiratory Syncytial Virus (RSV) Infection Among Adults in Nursing and Care Homes: A Systematic Review (2024 · Influenza and Other Respiratory Viruses · 被引 26)
• Detection by Nasopharyngeal Swabs Alone Underestimates Respiratory Syncytial Virus–Related Hospitalization Incidence in Adults: The Multispecimen Study's Final Analysis (2025 · The Journal of Infectious Diseases · 被引 24)